NCT07099469Active, not recruiting
Compairing R-ICNB and C-ICNB for Postoperative Pain Management After Minimal-invasive Anatomical Lung Resection
A Randomized Pilot Study of ICNB With Ropivacaine Versus ICNB With Cryotherapy for Postoperative Pain Management After RATS Anatomical Resection for Lung Cancer.
Source: ClinicalTrials.gov · Last updated 6 May 2026
Brief summary (registry, in English)
This is a pilot study in which a total of 6 people will participate. This study aims to optimize the postoperative pain management of an anatomically minimally invasive lung resection (RATS) by comparing 2 pain-relieving techniques. As standard, an intercostal block is placed at the end of the procedure by injecting a local anesthetic at the site where the patient will be operated on. This study compares the previous method with the use of cryotherapy as an intercostal block. This technique uses cryo probes and blocks postoperative pain for 1-3 months. By comparing both techniques, it is examined whether cryotherapy requires less pain medication and is therefore more effective.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 6 (estimated)
- First submitted
- 21 Mar 2025
- Start date
- 25 Mar 2025
- Primary completion date
- 1 Sept 2026
- Lead sponsor
- University Hospital, Antwerp
- Diseases
- Lung cancer
- NCT number
- NCT07099469
What you commit to
- Study type: Observational
- Planned participants: 6
- From 25 Mar 2025 to the primary completion date, 1 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have had thoracic surgery in the past.
Other illness
- Patients who need an anatomic resection of the lung that's larger than one lung lobe, who have CPAM or infections.
Lab values
- Patients with chronic kidney disease stage 4 or 5 (GFR \< 30 mL/min)
Other
- Patients with chronic use (\>3 months) of strong opioids because of co-morbidities -for example, the use of tramadol is allowed.
- If there's a high risk of conversion to a thoracotomy. This will be evaluated by the lung surgeon.
Who the study is looking for
- Adult patients of 18 years or older who are able to give informed consent and fill out questionnaires in Dutch.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Antwerp Coordinator of this site? Confirm its status | Edegem | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.